This text is a result of machine translation.
A new breakthrough in the first-line treatment of advanced esophageal cancer: PD-1 monoclonal antibody baizean ® Global phase 3 clinical trials reached the primary end point
Chongqing Municipal Bureau of water resources: it is estimated that the rainstorm and flood in Chongqing in 2022 will be more serious than that all year round
China’s Education Giant New Oriental Lost Around USD 900 Million After Crackdown
Since China banned the company from making a profit in the billion-dollar private education industry, on February 22, 2022, New Oriental reported a loss of USD 876 million for the six months to November 30, compared with a USD 229 million net profit over the same period of last year.
Feb 23, 2022 01:31 AM
Baiji China: the tentative list is a normal step and will not affect the listing of the company on NASDAQ
Ministry of agriculture and rural areas: implement the ten-year fishing ban on the Yangtze River in 2022 and promote the conservation of aquatic biological resources
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM